SPONSOR

Washington University School of Medicine

Total Trials

Recruiting

Phases

Phase 1, Phase 3, EARLY_Phase 1, Phase 2, Phase 1, Phase 2

Conditions studied: Lung Cancer Cancer of the Lung Depressive Disorder, Major Depressive Disorder, Treatment-Resistant Multiple Myeloma Obstructive Sleep Apnea Large B-cell Lymphoma Prostate Cancer Graft Vs Host Disease Graft-versus-host-disease

Washington University School of Medicine is a clinical research sponsor with 29 registered studies on ClinicalTrials.gov, of which 29 are actively recruiting participants. Research covers conditions including Lung Cancer, Cancer of the Lung, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant.

The trial portfolio spans Phase 1, Phase 3, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Washington University School of Medicine

How many clinical trials has Washington University School of Medicine sponsored?

ClinicalMetric currently tracks 29 clinical trials sponsored by Washington University School of Medicine, of which 29 are actively recruiting participants. These trials cover conditions including Lung Cancer, Cancer of the Lung, Depressive Disorder, Major. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Washington University School of Medicine research focus on?

Washington University School of Medicine clinical trials span Lung Cancer, Cancer of the Lung, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, Multiple Myeloma, and additional conditions. The research pipeline includes Phase 1, Phase 3, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Washington University School of Medicine clinical trial?

To participate in a Washington University School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Washington University School of Medicine trials with current recruitment status updated daily.

Washington University School of Medicine

Frequently Asked Questions — Washington University School of Medicine

Clinical Trials by Washington University School of Medicine

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma

Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Diffusion Basis Spectrum Imaging of the Prostate

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

PET Imaging CCR2 in Lung Inflammation

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Implementation of a Caregiver-Report Suicide-Risk Screener in Children Under Age 8 in a Behavioral Health Center

Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

Pain in Juvenile Arthritis

PET Detection of CCR2 in Human Atherosclerosis

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

Health Information for Persons With Spinal Cord Injury

Clinical Outcomes for Deep Brain Stimulation

HFrEF Polypill in Sri Lanka RCT

Role of the Gut Microbiome in Complex Regional Pain Syndrome

Nasal Obstruction With Oxymetazoline and Corticosteroids

Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement

AI-driven Clinical Decision Support for Perioperative Blood Orders